BR9914254A - Composição para o tratamento de doença de degeneração retinal lesada por luz - Google Patents

Composição para o tratamento de doença de degeneração retinal lesada por luz

Info

Publication number
BR9914254A
BR9914254A BR9914254-6A BR9914254A BR9914254A BR 9914254 A BR9914254 A BR 9914254A BR 9914254 A BR9914254 A BR 9914254A BR 9914254 A BR9914254 A BR 9914254A
Authority
BR
Brazil
Prior art keywords
treatment
light
composition
retinal degeneration
degeneration disease
Prior art date
Application number
BR9914254-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of BR9914254A publication Critical patent/BR9914254A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BR9914254-6A 1998-10-02 1999-09-29 Composição para o tratamento de doença de degeneração retinal lesada por luz BR9914254A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10297298P 1998-10-02 1998-10-02
US11070098P 1998-12-03 1998-12-03
PCT/JP1999/005321 WO2000020002A1 (en) 1998-10-02 1999-09-29 Composition for treatment of light-injured retinal degeneration disease

Publications (1)

Publication Number Publication Date
BR9914254A true BR9914254A (pt) 2001-07-03

Family

ID=26799937

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914254-6A BR9914254A (pt) 1998-10-02 1999-09-29 Composição para o tratamento de doença de degeneração retinal lesada por luz

Country Status (8)

Country Link
US (1) US6248759B1 (https=)
EP (1) EP1117404A1 (https=)
JP (1) JP2002526409A (https=)
AR (1) AR020681A1 (https=)
AU (1) AU5998399A (https=)
BR (1) BR9914254A (https=)
CA (1) CA2346086A1 (https=)
WO (1) WO2000020002A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005204391A1 (en) * 2004-01-14 2005-07-28 Lavipharm Laboratories, Inc. Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
WO1990006123A1 (en) * 1988-12-05 1990-06-14 Houston Biotechnology Incorporated Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction
FR2642307A1 (fr) * 1989-01-27 1990-08-03 Corbiere Jerome Medicament pour le traitement des maladies degeneratives de la retine et notamment des maladies conditionnees genetiquement, et un procede pour leur obtention
JP3041923B2 (ja) * 1990-06-27 2000-05-15 藤沢薬品工業株式会社 ジヒドロピリジン化合物を含有する抗炎症および活性酸素産生抑制剤
US5691360A (en) * 1993-12-08 1997-11-25 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
EP0911027A4 (en) 1996-04-26 2000-11-29 Fujisawa Pharmaceutical Co THE DIHYDROPYRIDINE CONTAINS TO IMPROVE THE CIRCULATION OF THE EYE-SURROUNDING TISSUE
JPH1072347A (ja) 1996-05-27 1998-03-17 Otsuka Pharmaceut Co Ltd 眼血管血流改善剤

Also Published As

Publication number Publication date
WO2000020002A1 (en) 2000-04-13
JP2002526409A (ja) 2002-08-20
EP1117404A1 (en) 2001-07-25
CA2346086A1 (en) 2000-04-13
AU5998399A (en) 2000-04-26
AR020681A1 (es) 2002-05-22
US6248759B1 (en) 2001-06-19

Similar Documents

Publication Publication Date Title
JO2371B1 (en) 4-phenyl-pyridine derivatives
EA200200183A1 (ru) Композиция, содержащая трамадол и противосудорожное лекарственное средство
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
WO2003048164A3 (en) Adenosine a2a receptor antagonists
BR0206381A (pt) Derivados do ácido fumárico como inibidor de nf-kappab
RU2003119545A (ru) Фармацевтические композиции для перорального введения фамакологических действующих веществ
CY1108105T1 (el) Ιβανδρονικο οξυ για την θεραπευτικη αντιμετωπιση και την προληψη της οστεoπορωσης
BG104544A (en) Novel acylguanadine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
BRPI0408681A (pt) compostos, composições farmacêuticas, uso de um derivado da 1,2,3,4-tetraidroisoquinolina, método para tratar ou prevenir doenças, processo para a manufatura de composições farmacêuticas, e, uso de um ou mais compostos
ATE332138T1 (de) Flibanserin zur behandlung extrapyramidaler bewegungsstörungen
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
WO2010005580A3 (en) Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity
BRPI0413186A (pt) composição de fexofenadina e processo para preparação da mesma
UA84896C2 (ru) Производные гидронопола как агонисты человеческих рецепторов orl1
PT1562954E (pt) Antagonistas de ccr1 para o tratamento da doenca desmielinzante inflamatoria i.a.
ID29025A (id) Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
SE0002729D0 (sv) Novel compound form
BR0014598A (pt) Combinações sinérgicas de um antagonista de receptor nk, e um análogo estrutural gaba
BR0105787A (pt) Composição farmacêutica, uso de um composto farmacêutico, método para tratamento de distúrbios, composto farmacêutico e método para confeccionar um composto farmacêutico
BR9914254A (pt) Composição para o tratamento de doença de degeneração retinal lesada por luz
HUP0004900A2 (hu) Mozgászavarok kezelésére szolgáló, hatóanyagként NMDA-receptor antagonista hatású piperidinszármazékokat tartalmazó gyógyszerkészítmények
EP1123923A4 (en) DIHYDROPYRIDINE DERIVATIVES AND DRUG BLOCK CONTAINING THESE
IE780217L (en) 1,3,5-triazine-2,6-dione derivatives
SE9901572D0 (sv) New compounds

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]